Search alternatives:
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
genes decrease » teer decrease (Expand Search), sizes decrease (Expand Search), greatest decrease (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
genes decrease » teer decrease (Expand Search), sizes decrease (Expand Search), greatest decrease (Expand Search)
-
1
-
2
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
3
-
4
Mean scores, standard deviations, and significance on key measures and subscales by gender group.
Published 2025Subjects: -
5
-
6
-
7
-
8
Pan-cancer analyses of ACADM expression and its prognostic significance in the TCGA database.
Published 2025Subjects: -
9
-
10
-
11
Pan-cancer analyses of ANGPTL4 expression and its prognostic significance in the TCGA database.
Published 2025Subjects: -
12
Pan-cancer analyses of NFKB2 expression and its prognostic significance in the TCGA database.
Published 2025Subjects: -
13
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
14
-
15
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
16
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
17
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
18
Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort.
Published 2025Subjects: -
19
EF-24 treatment significantly reduces cell viability in leukemia cell lines.
Published 2025Subjects: -
20
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: